Benzinga
@Benzinga
Financial News, Data & Education 💸
加入 June 2009
849 正在關注 343.9K 粉絲
Kodiak Sciences ($KOD) says Zenkuda and tabirafusp-ted matched Regeneron’s ($REGN) Eylea in a Phase 3 wet AMD trial.
Zenkuda also showed durable vision gains, with 54% of patients maintaining improvement for six months.
顯示更多
